Benzamide, N-[(3b,4b,5a,16b,20S)-20-(dimethylamino)-16-hydroxy-4-(hydroxymethyl)-4,14-dimethyl-9,19-cyclopregn-6-en-3-yl]- (18050-99-2)

Identification
Name:	Benzamide, N-[(3b,4b,5a,16b,20S)-20-(dimethylamino)-16-hydroxy-4-(hydroxymethyl)-4,14-dimethyl-9,19-cyclopregn-6-en-3-yl]-
Synonyms:	Benzamide,N-[20a-(dimethylamino)-16b-hydroxy-4b-(hydroxymethyl)-4,14-dimethyl-9,19-cyclo-5a,9b-pregn-6-en-3b-yl]- (8CI); Buxidine (7CI);1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, benzamide deriv.;9,19-Cyclopregnane, benzamide deriv.; Buxidin
CAS:	18050-99-2
Molecular Formula:	C33H48 N2 O3
Molecular Weight:	0
Molecular Structure:
Properties
Safety Data

Other Product

Benzamide, N-[(3b,4a,5a,16a,20S)-20-(dimethylamino)-16-hydroxy-4-(hydroxymethyl)-4,14-dimethyl-9,19-cyclopregn-6-en-3-yl]-N-methyl-(9CI)
Benzamide, N-[(3b,4b,5a,16b,20S)-4-(acetyloxy)-20-(dimethylamino)-16-hydroxypregnan-3-yl]-N-methyl-(9CI)
Benzamide, N-[(3a,4b,5a,16b,20S)-4-(acetyloxy)-20-(dimethylamino)-16-hydroxypregnan-3-yl]-N-methyl-
Acetamide, N-[(3b,4b,5a)-11-hydroxy-4,14-dimethyl-3-(methylamino)-9,19-cyclopregn-6-en-20-yl]-N-methyl-(9CI)
Benzamide, N-[(3b,4b,5a,20S)-20-(dimethylamino)-4-hydroxypregnan-3-yl]- (9CI)
Benzamide, N-[(2b,3b,4b,5a,20S)-4-(acetyloxy)-20-(dimethylamino)-2-hydroxypregnan-3-yl]-(9CI)
9,19-Cyclopregnan-16-one,3-(dimethylamino)-4-(hydroxymethyl)-4,14-dimethyl-20-(methylamino)-, (3b,4b,5a,20S)- (9CI)
9,19-Cyclopregn-6-ene-4-methanol,3,20-bis(dimethylamino)-16-hydroxy-4,14-dimethyl-, (3b,4a,5a,16a,20S)- (9CI)
Benzamide, N-[(3b,4b,5a,12b,20S)-4-(acetyloxy)-20-(dimethylamino)-12-hydroxypregnan-3-yl]-N-methyl-(9CI)
9,19-Cyclopregnan-11-one,3-amino-20-(dimethylamino)-16-hydroxy-4-(hydroxymethyl)-4,14-dimethyl-, (3b,4a,5a,16a,20S)-
9,19-Cyclopregn-6-ene-4-methanol, 3-(dimethylamino)-16-hydroxy-4,14-dimethyl-20-(methylamino)-, (3beta,4beta,5alpha,16alpha,20S)-
2-Butenamide, N-[(3b,4b,5a,20S)-4-(acetyloxy)-20-(dimethylamino)pregnan-3-yl]-3-methyl-
9,19-Cyclopregn-17(20)-en-16-one,3-(dimethylamino)-4,14-dimethyl-, (3b,4a,5a,17E)-
9,19-Cyclopregn-6-en-16-ol,3-(dimethylamino)-4,4,14-trimethyl-20-(methylamino)-, (2E)-2-methyl-2-butenoate(ester), (3b,5a,16a,20S)- (9CI)
6'H-9,19-Cyclopregn-3-eno[3,4-d][1,3]oxazin-16-ol,2',3,3',4-tetrahydro-2',3',4,14-tetramethyl-20-(methylamino)-, (3a,4b,5a,16a,20S)- (9CI)
9,19-Cyclopregn-1-en-3-one,16-hydroxy-4,4,14-trimethyl-20-(methylamino)-, (5a,16a,20S)- (9CI)
6'H-9,19-Cyclopregn-3-eno[3,4-d][1,3]oxazin-11-one,20-(dimethylamino)tetrahydro-16-hydroxy-4,14-dimethyl-, (3a,4a,5a,16a,20S)- (9CI)
Acetamide, N-[(2b,3b,4b,5a,20S)-2-(acetyloxy)-4-(benzoyloxy)-20-(dimethylamino)pregnan-3-yl]-(9CI)
2-Butenamide, N-[(3b,4b,5a,20S)-4-(acetyloxy)-20-(dimethylamino)pregnan-3-yl]-2-methyl-, (2E)-
2-Butenamide, N-[(2b,3b,4b,5a,20S)-4-(acetyloxy)-20-(dimethylamino)-2-hydroxypregnan-3-yl]-2-methyl-,(2E)- (9CI)